ilmscore | Prediction Details
"$15 billion in annual revenue is at risk by 2028 from expiring exclusivity on major drugs like Ebrance, Excandi, and Eloquis."
By Millionaires Investment Secrets | July 30, 2025 | Pending
From video
WHY Smart Money Is Rotating?? 3 Stocks To Watch Before The Correction Hits - Are You Prepared? 00:04:36 - 00:04:46
Interpreted Prediction
Pfizer faces a risk of losing $15 billion in annual revenue by 2028 due to patent expirations on key drugs (Ebrance, Excandi, Eloquis).

Prediction Details

Ticker
PFE
Initial Price
23.81 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.